Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)

NCT02202616 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

401

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Glycopyrronium /Indacaterol maleate

Sponsor

Novartis Pharmaceuticals